204 related articles for article (PubMed ID: 36915467)
1. Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma.
Liu Q; Gu L; Qiu J; Qian J
J Gastrointest Oncol; 2023 Feb; 14(1):245-264. PubMed ID: 36915467
[TBL] [Abstract][Full Text] [Related]
2. ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma.
Zhang Y; Pang S; Sun B; Zhang M; Jiao X; Lai L; Qian Y; Yang N; Yang W
Front Oncol; 2022; 12():884066. PubMed ID: 35912257
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
[TBL] [Abstract][Full Text] [Related]
4. NDC1 is a Prognostic Biomarker and Associated with Immune Infiltrates in Colon Cancer.
Liu M; Yuan R; Liu S; Xue Y; Wang X
Int J Gen Med; 2021; 14():8811-8817. PubMed ID: 34858049
[TBL] [Abstract][Full Text] [Related]
5. High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.
Wei Z; Duan X; Li Q; Li Q; Wang Y
J Gastrointest Oncol; 2021 Dec; 12(6):2966-2984. PubMed ID: 35070423
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.
Liu C; Wu S; Lai L; Liu J; Guo Z; Ye Z; Chen X
BMC Bioinformatics; 2023 Jan; 24(1):4. PubMed ID: 36597032
[TBL] [Abstract][Full Text] [Related]
7. PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration.
Liu X; Zhang Y; Wang Z; Liu L; Zhang G; Li J; Ren Z; Dong Z; Yu Z
J Hepatocell Carcinoma; 2021; 8():1495-1511. PubMed ID: 34881207
[TBL] [Abstract][Full Text] [Related]
8. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of
Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
Front Genet; 2022; 13():959832. PubMed ID: 36299588
[No Abstract] [Full Text] [Related]
11. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma.
Qu C; Ma T; Yan X; Li X; Li Y
Math Biosci Eng; 2022 Jan; 19(3):3069-3090. PubMed ID: 35240821
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
Mo M; Ma X; Luo Y; Tan C; Liu B; Tang P; Liao Q; Liu S; Yu H; Huang D; Zeng X; Qiu X
BMC Cancer; 2022 Oct; 22(1):1098. PubMed ID: 36289466
[TBL] [Abstract][Full Text] [Related]
14. AP4M1 as a prognostic biomarker associated with cell proliferation, migration and immune regulation in hepatocellular carcinoma.
Peng Y; Li X; Kang K; Zhou Y
Cancer Cell Int; 2023 Oct; 23(1):235. PubMed ID: 37821948
[TBL] [Abstract][Full Text] [Related]
15. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
Zhu G; Xia H; Tang Q; Bi F
Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
17. Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer.
Shen Q; Li J; Zhang C; Pan X; Li Y; Zhang X; En G; Pang B
Aging (Albany NY); 2023 Sep; 15(18):9779-9796. PubMed ID: 37733696
[TBL] [Abstract][Full Text] [Related]
18. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
Chen X; Sun M; Feng W; Chen J; Ji X; Xie M; Huang W; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
Front Genet; 2023; 14():1056000. PubMed ID: 36845390
[No Abstract] [Full Text] [Related]
19. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
